When Lucas was diagnosed with a rare form of brain tumor at the age of six, the prognosis seemed grim. French doctor Jacques Grill recalls the emotional moment of informing Lucas’s parents that their son’s life was in jeopardy. However, against all odds, seven years later, Lucas, now 13, shows no signs of the once-deadly tumor.
Researchers at the Gustave Roussy cancer center in Paris claim that Lucas is the first child globally to be cured of brainstem glioma, specifically diffuse intrinsic pontine glioma (DIPG), a particularly aggressive cancer. This tumor afflicts approximately 300 children in the United States and up to 100 in France annually.
As the medical community applauds the progress in childhood cancer treatment, with 85 percent of children surviving over five years post-diagnosis, the situation for those with DIPG remains dire. Typically, most children with this tumor do not survive beyond a year after diagnosis, and only 10 percent were reported to be alive two years later. While radiotherapy can sometimes slow the tumor’s progression, no effective drug against DIPG has been identified.
The story of Lucas defying the odds serves as a beacon of hope and underscores the challenges in treating this aggressive form of childhood cancer. This comes ahead of International Childhood Cancer Day, highlighting both advancements and the continued need for breakthroughs in pediatric oncology.
